ContributorsPublishersAdvertisers

#Otic

modernreaders.com

Zacks: Brokerages Expect Otonomy, Inc. (NASDAQ:OTIC) to Announce -$0.17 EPS

According to Zacks, analysts expect that Otonomy will report full year earnings of ($0.79) per share for the current financial year, with EPS estimates ranging from ($0.80) to ($0.78). For the next fiscal year, analysts expect that the company will report earnings of ($0.73) per share, with EPS estimates ranging from ($0.86) to ($0.60). Zacks Investment Research’s earnings per share averages are an average based on a survey of research analysts that that provide coverage for Otonomy.
FINANCIAL REPORTS
Picture for Zacks: Brokerages Expect Otonomy, Inc. (NASDAQ:OTIC) to Announce -$0.17 EPS
modernreaders.com

Squarepoint Ops LLC Decreases Stake in Otonomy, Inc. (NASDAQ:OTIC)

Squarepoint Ops LLC decreased its position in Otonomy, Inc. (NASDAQ:OTIC) by 70.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 59,686 shares of the biopharmaceutical company’s stock after selling 141,983 shares during the period. Squarepoint Ops LLC owned 0.11% of Otonomy worth $133,000 as of its most recent filing with the SEC.
STOCKS
Picture for Squarepoint Ops LLC Decreases Stake in Otonomy, Inc. (NASDAQ:OTIC)
com-unik.info

Otonomy (NASDAQ:OTIC) Cut to “Sell” at Zacks Investment Research

Zacks Investment Research lowered shares of Otonomy (NASDAQ:OTIC) from a hold rating to a sell rating in a research report released on Tuesday morning, Zacks.com reports. According to Zacks, “Otonomy, Inc. engages in developing and commercializing therapeutics to address unmet medical needs in the otology market. It develops therapeutics for treatment of inner and middle ear disorders. The Company’s product candidates under development includes AuriPro to treat pediatric patients with middle ear effusion; and OTO-104 for the treatment of patients with Ménière’s disease. Otonomy, Inc. is headquartered in San Diego, California. “
STOCKS
TRENDING TOPICS
tickerreport.com

Renaissance Technologies LLC Increases Stake in Otonomy, Inc. (NASDAQ:OTIC)

Renaissance Technologies LLC grew its position in shares of Otonomy, Inc. (NASDAQ:OTIC) by 3.5% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 723,026 shares of the biopharmaceutical company’s stock after buying an additional 24,161 shares during the quarter. Renaissance Technologies LLC’s holdings in Otonomy were worth $1,612,000 as of its most recent filing with the SEC.
STOCKS
veterinarypracticenews.com

Tips for evaluating computed tomography

The introduction of the latest technology into a practice can lead to diagnoses veterinarians cannot catch with other equipment. Computed tomography (CT) technology is a great example. Knowing what CT technology can do, how to forecast return on investment (ROI), and how it can improve patient health is key to deciding whether to invest in this technology.
HEALTH
modernreaders.com

Otonomy (NASDAQ:OTIC) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research downgraded shares of Otonomy (NASDAQ:OTIC) from a hold rating to a sell rating in a research note published on Tuesday, Zacks.com reports. According to Zacks, “Otonomy, Inc. engages in developing and commercializing therapeutics to address unmet medical needs in the otology market. It develops therapeutics for treatment of inner and middle ear disorders. The Company’s product candidates under development includes AuriPro to treat pediatric patients with middle ear effusion; and OTO-104 for the treatment of patients with Ménière’s disease. Otonomy, Inc. is headquartered in San Diego, California. “
SAN DIEGO, CA
theenterpriseleader.com

Otonomy (NASDAQ:OTIC) Announces Quarterly Earnings Results

Otonomy stock traded up $0.12 during midday trading on Friday, hitting $2.25. 161,510 shares of the stock were exchanged, compared to its average volume of 230,811. Otonomy has a 52-week low of $1.14 and a 52-week high of $6.98. The stock has a market capitalization of $127.53 million, a price-to-earnings ratio of -2.78 and a beta of 1.79. The business’s 50-day moving average price is $1.84 and its 200-day moving average price is $1.96. The company has a quick ratio of 11.25, a current ratio of 9.17 and a debt-to-equity ratio of 0.24.
FINANCIAL REPORTS
thefastmode.com

Orange Opens First Open RAN Integration Center in France

Orange has opened its Open RAN Integration Center in France, dedicated to Open RAN technology, a reference technology for future mobile networks. This testing and integration space, which will enable companies from the Open RAN ecosystem to test and validate their products and services, and thus accelerate the development of this technology, is the first of its kind to open in France. Convinced that Open RAN will be a pillar technology for future mobile networks, Orange invest in its development and plans to deploy in the coming years.
TECHNOLOGY
mobileeurope.co.uk

France's first lab for testing and developing Open RAN opens near Paris

Orange France has launched its Open RAN Integration Center in Châtillon, near Paris. Now every type of kit, from Amphenol antennas, through Samsung and Nokia networking kit to Viavi's testing and measuring equipment can be validated for its suitability for Open Radio Access Networking in Orange’s 5G networks, as the mobile operator group aims to phase out proprietary technology by 2025.
TECHNOLOGY
Register Citizen

Otonomy: Q3 Earnings Snapshot

SAN DIEGO (AP) _ Otonomy Inc. (OTIC) on Wednesday reported a loss of $12.9 million in its third quarter. On a per-share basis, the San Diego-based company said it had a loss of 19 cents. _____. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research....
FINANCIAL REPORTS
Benzinga

Current Stock Price for Otonomy (OTIC)?

There are no upcoming dividends for Otonomy. Otonomy’s $Q4 earnings are confirmed for after-market on $February 10, 2022. There is no upcoming split for Otonomy. What sector and industry does Otonomy (OTIC) operate in?. A. Otonomy is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on...
FINANCIAL REPORTS
YOU MAY ALSO LIKE